Nirmatrelvir Plus Ritonavir for Ambulatory COVID-19: Expanding Evidence, Expanding Role

被引：2
|
作者：
Anesi, George L. L. [1 ]
Maguire, Christina [2 ]
机构：
[1] Univ Penn, Perelman Sch Med, Div Pulm Allergy & Crit Care, 3400 Spruce St,5037 Gates Bldg, Philadelphia, PA 19104 USA
[2] Penn Presbyterian Med Ctr, Dept Pharm, Philadelphia, PA USA
来源：
ANNALS OF INTERNAL MEDICINE | 2023年 / 176卷 / 01期
关键词：
D O I：
10.7326/M22-3427
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：133 / 134
页数：2
相关论文
共 50 条
  • [1] Nirmatrelvir plus ritonavir in COVID-19: a profile of its use
    Hannah A. Blair
    [J]. Drugs & Therapy Perspectives, 2023, 39 : 41 - 47
  • [2] Nirmatrelvir plus ritonavir in COVID-19: a profile of its use
    Blair, Hannah A.
    [J]. DRUGS & THERAPY PERSPECTIVES, 2023, 39 (02) : 41 - 47
  • [3] Nirmatrelvir-ritonavir for COVID-19
    McDonald, Emily G.
    Lee, Todd C.
    [J]. CANADIAN MEDICAL ASSOCIATION JOURNAL, 2022, 194 (06) : E218 - E218
  • [4] Nirmatrelvir Plus Ritonavir for COVID-19: The First Step Is Getting the Name Right
    Wisniewski, Piotr
    Berjohn, Catherine M.
    Maves, Ryan C.
    [J]. MILITARY MEDICINE, 2023, 188 (1-2) : 34 - 35
  • [5] Nirmatrelvir/ritonavir combination against COVID-19
    McDonald, Emily G.
    Lee, Todd C.
    [J]. CANADIAN MEDICAL ASSOCIATION JOURNAL, 2022, 194 (09) : E365 - E366
  • [6] Nirmatrelvir/Ritonavir for hemodialysis patients with COVID-19
    Lu, Jiayue
    Cai, Hong
    Hao, Yujun
    Lin, Zhang
    Liu, Shang
    Zhan, Yaping
    Ding, Li
    Huang, Meilan
    Li, Zhenyuan
    Xu, Lan
    Yan, Xiujuan
    Yang, Li
    Zhang, He
    Zhang, Wei
    Zhao, Li
    Zhao, Junli
    Wang, Ting
    Gu, Leyi
    [J]. FRONTIERS IN PHARMACOLOGY, 2023, 14
  • [7] Clinical Effectiveness of Nirmatrelvir plus Ritonavir in the Treatment of COVID-19 for Patients With Dementia
    Liu, Ting-Hui
    Hsu, Wan-Hsuan
    Tsai, Ya-Wen
    Wu, Jheng-Yan
    Chuang, Min-Hsiang
    Lai, Chih-Cheng
    Huang, Po-Yu
    [J]. JOURNAL OF THE AMERICAN MEDICAL DIRECTORS ASSOCIATION, 2023, 24 (08) : 1159 - 1162
  • [8] Clinical effectiveness of nirmatrelvir plus ritonavir in the treatment of COVID-19 in patients with cirrhosis
    Hsu, Wan-Hsuan
    Shiau, Bo-Wen
    Liu, Ting-Hui
    Wu, Jheng-Yan
    Tsai, Ya-Wen
    Huang, Po-Yu
    Chuang, Min-Hsiang
    Lai, Chih-Cheng
    Chen, Chi-Hsing
    [J]. EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2023, 21 (10) : 1143 - 1151
  • [9] Nirmatrelvir/ritonavir for COVID-19: an overview of systematic reviews
    Cruciani, Mario
    Pati, Ilaria
    Masiello, Francesca
    Pupella, Simonetta
    De Angelis, Vincenzo
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2024, 79 (03) : 477 - 497
  • [10] Clinical effectiveness of nirmatrelvir plus ritonavir for patients with COVID-19 and preexisting psychiatric disorders
    Liu, Ting-Hui
    Wu, Jheng-Yan
    Huang, Po-Yu
    Hsu, Wan-Hsuan
    Chuang, Min-Hsiang
    Tsai, Ya-Wen
    Lai, Chih-Cheng
    Huang, Charles Lung-Cheng
    [J]. EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2024,
12345